Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 986 of 5804
-
Engineered immune cells take on lupus kidney disease in early trial
Disease control TerminatedThis multi-center, open-label, Phase 1/2 study aims to evaluate the safety, tolerability, and preliminary efficacy of C-CAR168, an autologous anti-CD20/BCMA CAR-T therapy, in patients with autoimmune diseases refractory to standard treatments. The study includes both dose escalat…
Phase: PHASE1, PHASE2 • Sponsor: AbelZeta Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can skipping opioids during surgery curb addiction? new trial aims to find out
Disease control TerminatedIn the current opioid crisis, the use of opioids as the main pain management method is recognized as a consistent risk factor for chronic opioid use and the development of Opioid Use Disorder (OUD), as well as related complications like overdose fatalities among surgical patients…
Phase: EARLY_PHASE1 • Sponsor: Jacques E. Chelly • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Sponge treatment may fix dangerous gut leaks without more surgery
Disease control Recruiting nowThis study is intended to evaluate the safety and effectiveness of Sponge-based Endoscopic Vacuum Therapy (EVT) using Endo-SPONGE for the treatment of Anastomotic Leaks (AL) or Hartmann's stump leakages following colorectal surgery in a prospective multi-center study.
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New monitor could prevent dangerous side effect of diabetes drug
Disease control Not yet recruitingThis research study is being conducted to learn if wearing a combination continuous glucose monitor/continuous ketone monitor (CGM/CKM) can reduce the side effects of taking sotagliflozin (study drug) in people with type 1 diabetes.
Phase: PHASE3 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Can a common heart drug reverse scarring in stiff heart failure?
Disease control Not yet recruitingCardiac magnetic resonance imaging (MRI) measures of myocardial interstitial fibrosis (MIF) are elevated in heart failure with preserved ejection fraction (HFpEF) patients and associated with poor prognosis. Extracellular volume (ECV) is the most reproducible and best validated c…
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New Triple-Drug attack on tough leukemia enters human testing
Disease control Not yet recruitingThis study is to evaluate the safety and preliminary efficacy of adding the PI3K-gamma inhibitor, eganelisib, to a standard of care treatment option with combination venetoclax and azacitidine in participants with acute myeloid leukemia (AML). The names of the study drugs involv…
Phase: PHASE1 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New trial aims to stop CMV eye inflammation from returning
Disease control Not yet recruitingThe goal of this clinical trial is to compare antiviral treatment strategies for cytomegalovirus (CMV) anterior uveitis - a viral infection causing inflammation inside the front of the eye - in immunocompetent adults aged 18 years and older. The main questions it aims to answer a…
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Modified herpes virus takes on bile duct cancer in new trial
Disease control Not yet recruitingVG2025 is a Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 Injection. Currently, one phase I dose escalation safety study has been completed in China and the United States respectively, both demonstrating excellent safety profiles with no dose-limiting toxicities (DLTs)…
Phase: PHASE2 • Sponsor: Virogin Biotech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New hope for tough pancreatic cancer? experimental combo enters human testing
Disease control Not yet recruitingThe primary purpose of this study is to determine the safety and recommended dose level (RDL) of BLEX 404 Oral Liquid combined with Gemcitabine monotherapy in a 28-day schedule.The secondary purpose is to assess the efficacy and safety of BLEX 404 Oral Liquid combined with Gemcit…
Phase: PHASE2 • Sponsor: Rgene Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Spring implant aims to ease prostate troubles in Real-World study
Symptom relief Not yet recruitingThe purpose of this registry is to collect information on how the Zenflow Spring System works in everyday medical practice. The registry will track how the Spring System performs during the implant procedure, and at follow-up visits at 1, 3, 6, and 12 months. We will look at how …
Sponsor: Zenflow, Inc. • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
New antibiotic strategy could shorten hospital stays for heart infections
Disease control Not yet recruitingCardiac infections, including infective endocarditis and cardiovascular implantable electronic device infections, are associated with substantial morbidity and mortality and are commonly caused by gram-positive bacteria. Standard management typically requires prolonged courses of…
Phase: PHASE2 • Sponsor: Kirby Institute • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New diabetes shot could cut injections to once a month
Disease control Not yet recruitingSemaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is an approved and well-established therapy for type 2 diabetes mellitus (T2DM), providing both robust glycemic control and weight reduction. Semaglutide Depot, is a long-acting formulation of semaglutide, designed …
Phase: PHASE1, PHASE2 • Sponsor: Mapi Pharma Ltd. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug combo targets aggressive brain cancer in early trial
Disease control Not yet recruitingThis is a Phase 1, single-arm MT-125 dose escalation study followed by a Phase 2, randomized parallel design dose expansion phase, to determine the safety and tolerability of MT-125 administered 5 consecutive days a week with 2 days off for the 6 weeks of outpatient treatment of …
Phase: PHASE1, PHASE2 • Sponsor: Myosin Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New CAR-T therapy RN9101 targets Hard-to-Treat myeloma
Disease control Not yet recruitingThis is a single arm, open-label, dose escalation, phase 1 study to evaluate the safety, tolerability, preliminary efficacy, pharmacokinetics, pharmacodynamics and immunogenicity of RN9101 injection for patients with relapsed/refractory multiple myeloma.
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New heart device registry aims to tame irregular heartbeat
Disease control Not yet recruitingThis post-market registry is designed to collect real world data on the use of the Globe PF System for the treatment of atrial fibrillation (AF).
Sponsor: Kardium Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Major trial tests if early aspirin stop is safe for Moms-to-Be
Prevention Not yet recruitingPregnant women at higher risk for preeclampsia (PE) are currently recommended to take low-dose aspirin (acetylsalicylic acid, ASA) daily from the first trimester until 36 weeks of gestation. High-risk women are identified through a multiparametric first-trimester screening that c…
Phase: PHASE3 • Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Heart failure drug vericiguat faces new test in tricuspid regurgitation patients
Disease control Not yet recruitingThe goal of this clinical trial is to learn if the drug vericiguat works to improve right heart function in patients with worsening heart failure who have reduced left ventricular function. It will also examine the effects of the drug on tricuspid regurgitation (TR) and overall c…
Phase: PHASE4 • Sponsor: Daejeon St. Mary's hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Oral asthma drug KT-621 tested for Long-Term safety
Disease control Recruiting nowThis Phase 2b open-label, long-term extension study is designed to evaluate the long-term safety and efficacy of KT-621 in participants with asthma who were previously enrolled in the parent study (KT621-AS-202) of KT-621 for asthma. The main goals of this study are to investigat…
Phase: PHASE2 • Sponsor: Kymera Therapeutics, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Simple blood tests could spot liver cancer earlier in diabetics
Disease control Not yet recruitingLiver cancer is a significant malignancy in Taiwan. With the widespread implementation of antiviral therapies, hepatitis B and C-related liver cancer has gradually declined; however, metabolic dysfunction-associated liver cancer continues to increase, particularly among patients …
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Can a two-drug combo better tame prostate trouble?
Symptom relief Recruiting nowThis study aims to evaluate the short-term impact and clinical outcomes of tamsulosin monotherapy versus combination therapy with tamsulosin plus tadalafil (2.5 mg vs. 5 mg) on lower urinary tract symptoms (LUTS) severity and patient quality of life in men with benign prostatic h…
Phase: NA • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC